perfluorooctane sulfonic acid has been researched along with Body Weight, Fetal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, S; Wan, HT; Wong, AY; Wong, CK | 1 |
| Ge, RS; Ge, Y; Li, X; Lian, QQ; Liang, Y; Wei, J; Ye, L; Yuan, K; Zhang, Y; Zhao, C; Zhu, X | 1 |
| Barbee, BD; Butenhoff, JL; Grey, BE; Hanson, RG; Lau, C; Richards, JH; Rogers, JM; Stevenson, LA; Thibodeaux, JR | 1 |
3 other study(ies) available for perfluorooctane sulfonic acid and Body Weight, Fetal
| Article | Year |
|---|---|
Effects of
Topics: Alkanesulfonic Acids; Animals; Female; Fetal Weight; Fluorocarbons; Humans; Maternal Exposure; Mice; Placenta; Pregnancy | 2020 |
In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: A mechanism study.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alkanesulfonic Acids; Animals; Female; Fetal Growth Retardation; Fetal Weight; Fluorocarbons; Gene Expression Regulation; Maternal-Fetal Exchange; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Signal Transduction; Thinness | 2016 |
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Alkanesulfonic Acids; Animals; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Female; Fetal Weight; Fetus; Fluorocarbons; Liver; Maternal Exposure; Mice; Mice, Inbred Strains; Organ Size; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Teratogens; Thyroxine; Triglycerides; Triiodothyronine | 2003 |